Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Lawyer, C.
space
  arrow  Bakir, H.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Nasal Carriage of Staphylococcal Infection in Wegener Granulomatosis

right arrow Carl Lawyer, MD; Joseph Henkle, MD; and Haitham Bakir, MD

1 July 1994 | Volume 121 Issue 1 | Pages 74-75


TO THE EDITOR:

Stegeman and colleagues [1] reported the association of chronic nasal carriage of Staphylococcus aureus with higher relapse rates in Wegener granulomatosis and discussed the possibility of its causal role in autoimmune phenomena. The c-antineutrophil cytoplasmic antibody (c-ANCA) Wegener granulomatosis autoantigen is a serine protease with strong similarity to other trypsin-family serine proteases. It is homologous in its first 100 amino acids (with >50% identity) to granzyme B (a killer-cell-specific serine protease also known as cytotoxic T-lymphocyte proteinase-2, whose expression may be involved in the acute rejection of renal allografts and in apoptosis. This area of near identity includes areas of predicted high antigenicity using the Jameson-Wolf antigenicity index. Granzyme B is induced by S. aureus enterotoxin A. The protein sequence of granzyme B is encoded by a cDNA clone isolated from staphylococcal enterotoxin A-stimulated lymphocytes [2].

Could induction of serine proteases such as granzyme B by staphylococcal enterotoxin A result in antibody formation to serine protease epitopes manifested as c-ANCA?

Some prokaryotic proteases (including S. aureus) have a charge relay system similar to that in trypsin family serine proteases, including c-ANCA [3, 4]. These prokaryotic proteases probably evolved by independent convergent evolution, given that their sequences, except for the residues around the catalytic triad, are completely different from those of the analogous residues in the trypsin serine proteases. Proteases in this family include both S. aureus V8 proteinase, widely used in protein sequencing, and S. aureus epidermolytic toxins A and B, the proteolytic toxins that cause impetigo [3].

It is also possible that the S. aureus genome directly encodes other serine proteases with antigenic cross-reactivity to the c-ANCA autoantigen. The S. aureus million base pair genome should be sequenced.


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

Southern Illinois University School of Medicine; Springfield, IL 62794


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1. Stegeman CA, Cohen Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CG. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med. 1994; 120:12-7.

2. Caputo A, Fahey D, Lloyd C, Vozab R, McCairns E, Rowe PB. Structure and differential mechanisms of regulation of expression of a serine esterase gene in activated human T lymphocytes. J Biol Chem. 1988; 263:6363-9.

3. Dancer SJ, Garratt R, Saldanha J, Jhoti H, Evans R. The epidermolytic toxins are serine proteases. FEBS Lett. 1990; 268:129-32.

4. Bailey CJ, Smith TP. The reactive serine residue of epidermolytic toxin A. Biochem J. 1990; 269:535-7.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Lawyer, C.
space
  arrow  Bakir, H.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online